Status:
UNKNOWN
Individual Approach in Gynecological Cancer Brachytherapy
Lead Sponsor:
Institute of Oncology Ljubljana
Conditions:
Cancer
Eligibility:
FEMALE
18-85 years
Phase:
NA
Brief Summary
MRI guided adaptive brachytherapy (BT) represents the gold standard in the treatment of gynecological cancers. Commercially available standard MRI compatible applicators for BT of gynecological cancer...
Detailed Description
Patients with locoregionally gynecological cancers will be included in this single-institution, non-randomized, one-arm study. All patients will receive 45-50 Gy external beam radiotherapy (EBRT) with...
Eligibility Criteria
Inclusion
- patients with locally advanced gynecological cancer (cervical, uterine, vaginal, vulvar cancer) eligible for treatment with brachytherapy
- squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma, histologically proven
- patients fit for regional or general anesthesia
- signed written informed consent
Exclusion
- regional or general anesthesia contraindications
- contraindications for MRI
Key Trial Info
Start Date :
May 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03466957
Start Date
May 1 2016
End Date
January 1 2019
Last Update
March 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Oncology Ljubljana
Ljubljana, Slovenia, 1000